Skip to main content
. Author manuscript; available in PMC: 2022 Jun 23.
Published in final edited form as: ACS Appl Mater Interfaces. 2021 Jun 9;13(24):27972–27982. doi: 10.1021/acsami.1c07049

Figure 6.

Figure 6.

Brain nicotine concentrations. All mice that were treated with either nicotine vaccines or PBS buffer were subcutaneously administered with 0.07 mg/kg nicotine on day 120, and the brain nicotine concentrations were measured. *** denotes that the brain nicotine concentration in group 3 was significantly lower than that of the control (P-value is less than 0.05). ## denotes that the brain nicotine concentrations in groups 1, 2, 4, 5, and 6 were not significantly different from that of the control.